In human ovarian cancer cell lines overexpressing CD44, the encapsulated glycosylated paclitaxel liposomes (gPTX-L) conjugated with anti-CD44 antibody efficiently enhanced cytotoxicity in vitro and in vivo, suppressing tumour growth in vivo [211]. This evidence concerns the gene CD44 and ovarian carcinoma.